Note: Revo Biologics's revenues are gauged from an analysis of company filings.
Revo Biologics's Income Statement (based on Industry Averages)
Revo Biologics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Revo Biologics is developing and marketing.
Revo Biologics doesn't have any recent trademark applications, indicating Revo Biologics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
REVO BIOLOGICS Custom manufacture of pharmaceuticals, biosimilars, biopharmaceutical [ and veterinary ] preparations and proteins for the treatment of cancer, blood diseases, auto-immune diseases, infectious diseases and hereditary diseases
05/10/2012
ATRYN ANTITHROMBIN (RECOMBINANT) Pharmaceutical preparations and substances for the treatment of [ infectious diseases, ] blood disorders [, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders ] ; Pharmaceutical preparations for the prevention and treatment of disorders of [ the nervous system, the immune system, ] the cardio-vascular system, the metabolic system [, the respiratory system, the musculo-skeletal system, the genitourinary system ] ; for the treatment of inflammatory disorders; for use [ in dermatology, oncology, ] hematology [ and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders ] ; Pharmaceutical preparations for the treatment of antithrombin deficiency; Pharmaceutical preparations, namely, anticoagulants
04/14/2009
GTC BIOTHERAPEUTICS Custom manufacture of transgenic animal products, namely, pharmaceuticals, biopharmaceuticals and proteins
03/22/2007
See all trademarks and details in the Full Report.
Market Share of Revo Biologics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Revo Biologics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Revo Biologics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Revo Biologics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.